Literature DB >> 6341196

Natural history of hepatitis B virus infection in renal transplant recipients--a fifteen-year follow-up.

G Dusheiko, E Song, S Bowyer, M Whitcutt, G Maier, A Meyers, M C Kew.   

Abstract

Hepatitis B virus (HBV) markers were measured in 83 immunosuppressed renal transplant patients who were followed for periods of 2 to 15 years. Sixty-nine patients were negative for HBsAg before transplantation, of whom 14 were positive for anti-HBs. The remaining 14 patients were HBsAg positive prior to transplantation. Eighteen patients were identified as being HBsAg positive during the follow-up period. Four patients acquired primary type B hepatitis; one died of submassive hepatic necrosis and the remaining three became chronic HBV carriers with positive HBeAg, DNA polymerase, and HBV DNA. Several patterns of HBV expression were observed in HBsAg-positive patients. Four patients were HBsAg, HBeAg, DNA polymerase, and HBV DNA positive prior to transplantation, and these markers persisted. Reactivation of HBV replication occurred in eight patients, seven of whom were HBsAg positive and HBeAg and anti-HBe negative originally; one patient was anti-HBc positive. A single patient was HBsAg and anti-HBe positive and remained so for 22 months. The remaining previously HBsAg-positive patient is currently HBsAg negative. These serological data suggest that reactivation of HBV replication or continued hepatitis B virion replication occurs as commonly or more commonly than de novo infection in renal transplant recipients. The presence of HBeAg in serum predisposes to long-term Dane particle expression in immunosuppressed patients, whereas anti-HBe-positive carriers may not always be susceptible to reactivation of HBV replication despite immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341196     DOI: 10.1002/hep.1840030309

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

1.  Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance.

Authors:  Antje Knöll; Arndt Hartmann; Harald Hamoshi; Karin Weislmaier; Wolfgang Jilg
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

Review 2.  Management of patients with hepatitis B who require immunosuppressive therapy.

Authors:  Jessica P Hwang; Anna S-F Lok
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-11-19       Impact factor: 46.802

3.  Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.

Authors:  An Li; Quan Yuan; Zhiyin Huang; Jian Fan; Ruyi Guo; Bin Lou; Qin Zheng; Shengxiang Ge; Yixin Chen; Zhijun Su; Anthony E T Yeo; Yu Chen; Jun Zhang; Ningshao Xia
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

Review 4.  Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2013-10-17

Review 5.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

6.  Kidney transplantation in patients with chronic hepatitis B virus infection: is the prognosis worse?

Authors:  T I Huo; W C Yang; J C Wu; K L King; C C Loong; C Y Lin; F Y Chang; S D Lee
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

7.  Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia.

Authors:  K Ishiga; T Kawatani; T Suou; F Tajima; H Omura; Y Idobe; H Kawasaki
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

Review 8.  Acute liver failure due to hepatic involvement by hematologic malignancy.

Authors:  T M Shehab; M S Kaminski; A S Lok
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 9.  Dangers of immunosuppressive therapy in hepatitis B virus carriers.

Authors:  E Lueg; J Heathcote
Journal:  CMAJ       Date:  1992-10-15       Impact factor: 8.262

10.  Pancreatitis following liver transplantation.

Authors:  J A Alexander; A J Demetrius; J S Gavaler; L Makowka; T E Starzl; D H Van Thiel
Journal:  Transplantation       Date:  1988-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.